Cache (NASDAQ:CACH) shares hit a new 52-week low during mid-day trading on Wednesday following a weaker than expected earnings announcement, ARN reports. Cache, Inc. (NASDAQ:CACH) shares after opening at $3.00 moved to $3.16 on last trade day and at the end of the day closed at $ 3.11. Company price to sales ratio in past twelve months was calculated as 0.30 and price to cash ratio as 14.91. Cache, Inc. (NASDAQ:CACH) showed a negative weekly performance of -21.86 %.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) has earned an average recommendation of “Buy” from the eight analysts that are covering the company, Analyst Ratings.Net reports. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) shares advanced 0.50% in last trading session and ended the day on $10.12. TTPH return on equity ratio is recorded as -89.90% and its return on assets is -34.40%. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) yearly performance is 43.14%.
NewLead Holdings Ltd (NASDAQ:NEWL) recently issued preferred shares and obtained debt financing to increase its fleet by two eco-type vessels. About $25 million was raised through the preferred shares offering. NewLead Holdings Ltd (NASDAQ:NEWL) shares moved down -1.18% in last trading session and was closed at $1.67 while trading in range of $1.63 – $1.76 – NewLead Holdings Ltd (NASDAQ:NEWL) year to date (YTD) performance is -90.56%.
Celgene Corporation and Acceleron Pharma Inc. (NASDAQ:XLRN) announced the publication of two papers available online today and in the April issue of the journal Nature Medicine that describe how sotatercept and ACE-536 promote red blood cell formation through an erythropoietin (EPO) independent mechanism in mice. Acceleron Pharma Inc (NASDAQ:XLRN) weekly performance is -12.13%. On last trading day company shares ended up $34.28. Acceleron Pharma Inc (NASDAQ:XLRN) distance from 50-day simple moving average (SMA50) is -25.22%. Analysts mean target price for the company is $55.00.